Daily non-political popular news in brief.

Drug improves tremors, involuntary movements in Parkinson patients

A drug used to treat epilepsy has been found to significantly improve tremors, motor fluctuations and other involuntary movements, or dyskinesias, in patients with Parkinson disease, according to a study published in the Jan. 2, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

Read more »

Keywords: drug, improves, tremors, involuntary, movements, parkinson, patients, improve, tremor, movement, patient

« Previous | Next »

Similar news on "Drug improves tremors, involuntary movements in Parkinson patients":

1. Scientists identify 2 distinct Parkinson's networks
   07-09-2007 · EurekAlert!
   Parkinson's that causes tremors, rigidity and slowed movements also targets another brain network that regulates cognitive thought and the ability to carry out everyday tasks. David Eidelberg, MD, head of the Center for Neurosciences at the Feinstein Institute for Medical Research, and his colleagues measured and quantified this network of brain regions during a five-year study of newly diagnosed Parkinson's patients who agreed to be followed several times over the course of the study.
   Similar news · Read more »
   
2. Gene patenting -- steep cost for health care and patients
   05-07-2007 · EurekAlert!
   The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
   Similar news · Read more »
   
3. Deep brain stimulation offers new hope for dystonia treatment
   11-21-2006 · EurekAlert!
   Dystonia, a group of diseases that cause a patient's muscles to involuntary contract with movement, has had a relatively limited and ineffective number of treatments in the past. New research shows that a recently developed surgical treatment, deep brain stimulation (an off switch for the brain), has provided dramatic benefits in some patients.
   Similar news · Read more »
   
4. Cough medicine fights dyskinesias in Parkinson's
   11-07-2007 · EurekAlert!
   A cough suppressant and a drug tested against schizophrenia curb dyskinesias, the involuntary movements that are disabling side effects of taking the Parkinson's disease medication levodopa, Portland scientists found. Dextromethorphan, used in such cold and flu medications as Robitussin and Sucrets, suppresses dyskinesias in rats. BMY-14802, a drug tested in people with schizophrenia, also suppresses dyskinesias in rats, and does so more effectively than dextromethorphan, suggesting BMY-14802 might block dyskinesias in people with Parkinson's.
   Similar news · Read more »
   
5. Drug reduces daily 'off' time for Parkinson patients
   04-02-2007 · EurekAlert!
   Parkinson disease patients taking the drug, ropinirole 24-hour prolonged release significantly reduced their daily "off" time in which Parkinson's symptoms like tremor, slowness, stiffness and walking difficulty return as drugs wear off, according to a study published in the April 3, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
   Similar news · Read more »
   
6. Tonsillectomy significantly improves quality of life in adult and pediatric patients
   01-01-2008 · EurekAlert!
   Tonsillectomies to treat chronic and recurrent tonsillitis substantially improve a patient's quality of live in both children and adults, according to two new studies published as a supplement to the January 2008 issue of Otolaryngology-Head and Neck Surgery.
   Similar news · Read more »
   
7. Complete response with oblimersen combination improves survival of CLL patients
   12-09-2007 · EurekAlert!
   Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at the University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
   Similar news · Read more »
   
8. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
9. Research shows survival benefit for leukemia patients treated with arsenic trioxide
   06-04-2007 · EurekAlert!
   Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
   Similar news · Read more »
   
10. Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
    10-12-2006 · ScienceDaily
    By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
    Similar news · Read more »